Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALM1 | P0DP23 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTR1D | P28221 | 1/20 | 0.30 |
| ▸ | HTR1B | P28222 | 1/20 | 0.30 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12815140 | 0.84 | CYP2B6 (0.32) | CYP2B6TAAR1 | |
| SCHEMBL12815028 | 0.84 | CYP2B6 (0.35) | CALM1LMNACYP2D6MAPK1HTR1D | |
| SCHEMBL6255348 | 0.82 | CALM1 (0.38) | CALM1LMNACYP2D6HTR1DHTR1B | |
| SCHEMBL12814497 | 0.82 | KCNN4 (0.33) | CYP2B6TAAR1 | |
| SCHEMBL12814710 | 0.81 | CALM1 (0.37) | CALM1HRH3ALDH1A1 | |
| SCHEMBL12815058 | 0.79 | CNR1 (0.30) | — | |
| SCHEMBL12816122 | 0.76 | MAPK1 (0.32) | MAPK1CYP2B6TAAR1ALDH1A1ALOX15 | |
| SCHEMBL12814840 | 0.75 | KIF11 (0.38) | CYP2D6HRH3ALDH1A1 | |
| SCHEMBL16458745 | 0.75 | IDH1 (0.33) | CALM1LMNACYP2D6HTR1DHTR1B | |
| SCHEMBL12815462 | 0.74 | KIF11 (0.39) | CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140012056-A1 | METHOD FOR PRODUCING 1-HEXENE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140012056-A1 | METHOD FOR PRODUCING 1-HEXENE | AP2A1, AP1M1, ME1 | CALM1 1570/4885LMNA 3551/4885CYP2D6 547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.